{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:35:09Z","timestamp":1774989309452,"version":"3.50.1"},"reference-count":11,"publisher":"Japan Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej18-0542","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T22:02:38Z","timestamp":1555106558000},"page":"615-620","source":"Crossref","is-referenced-by-count":15,"title":["The clinical course and potential underlying mechanisms of everolimus-induced hyperglycemia"],"prefix":"10.1507","volume":"66","author":[{"given":"Jun","family":"Tanimura","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Homeostatic Regulation, National Institute for Physiological Sciences, National Institute of Natural Sciences, Aichi 444-8585, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachie","family":"Osada","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Kanazawa University Hospital, Ishikawa 920-8641, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"International Institute for Integrative Sleep Medicine, University of Tsukuba, Ibaraki 305-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumpei","family":"Tokuyama","sequence":"additional","affiliation":[{"name":"International Institute for Integrative Sleep Medicine, University of Tsukuba, Ibaraki 305-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinari","family":"Takamura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149: 274\u2013293.","DOI":"10.1016\/j.cell.2012.03.017"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Verg\u00e8s B, Cariou B (2015) mTOR inhibitors and diabetes. Diabetes Res Clin Pract 110: 101\u2013108.","DOI":"10.1016\/j.diabres.2015.09.014"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3 Tsuchiyama N, Takamura T, Ando H, Sakurai M, Shimizu A, et al. (2007) Possible role of \u03b1-cell insulin resistance in arginine in type 2 diabetes. Diabetes Care 30: 2583\u20132587.","DOI":"10.2337\/dc07-0066"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kato K, Takamura T, Takeshita Y, Ryu Y, Misu H, et al. (2014) Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease. PLoS One 9: e92170.","DOI":"10.1371\/journal.pone.0092170"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Zeng Z, Sarbassov DD, Samudio IJ, Yee KWL, Munsell MF, et al. (2007) Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Blood 109: 3509\u20133512.","DOI":"10.1182\/blood-2006-06-030833"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Um SH, D\u2019Alessio D, Thomas G (2006) Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3: 393\u2013402.","DOI":"10.1016\/j.cmet.2006.05.003"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7 Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, et al. (2012) Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335: 1638\u20131643.","DOI":"10.1126\/science.1215135"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Hagiwara A, Cornu M, Cybulski N, Polak P, Betz C, et al. (2012) Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab 15: 725\u2013738.","DOI":"10.1016\/j.cmet.2012.03.015"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9 Houde VP, Br\u00fbl\u00e9 S, Festuccia WT, Blanchard PG, Bellmann K, et al. (2010) Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes 59: 1338\u20131348.","DOI":"10.2337\/db09-1324"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kulke MH, Bergsland EK, Yao JC (2009) Glycemic control in patients with insulinoma treated with everolimus. N Engl J Med 360: 195\u2013197.","DOI":"10.1056\/NEJMc0806740"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Blandino-Rosano M, Barbaresso R, Jimenez-Palomares M, Bozadjieva N, Werneck-de-Castro JP, et al. (2017) Loss of mTORC1 signalling impairs \u03b2-cell homeostasis and insulin processing. Nat Commun 8: 16014.","DOI":"10.1038\/ncomms16014"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/7\/66_EJ18-0542\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T03:39:45Z","timestamp":1564803585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/7\/66_EJ18-0542\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0542","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}